Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial

Diabetic Medicine ◽

10.1111/j.1464-5491.2010.03152.x ◽

2010 ◽

Vol 28 (1) ◽

pp. 109-116 ◽

Cited By ~ 85

Author(s):

J. Satoh ◽

S. Yagihashi ◽

M. Baba ◽

M. Suzuki ◽

A. Arakawa ◽

...

Keyword(s):

Neuropathic Pain ◽

Peripheral Neuropathy ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial

Pain ◽

10.1016/j.pain.2004.05.001 ◽

2004 ◽

Vol 110 (3) ◽

pp. 628-638 ◽

Cited By ~ 462

Author(s):

Julio Rosenstock ◽

Michael Tuchman ◽

Linda LaMoreaux ◽

Uma Sharma

Keyword(s):

Peripheral Neuropathy ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

A randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of TRPA1, in patients with painful diabetic peripheral neuropathy

Pain ◽

10.1097/j.pain.0000000000002470 ◽

2021 ◽

Vol Publish Ahead of Print ◽

Author(s):

Sunil M. Jain ◽

R. Balamurugan ◽

Monika Tandon ◽

Neelufar Mozaffarian ◽

Girish Gudi ◽

...

Keyword(s):

Peripheral Neuropathy ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

290 EFFICACY AND SAFETY OF PREGABALIN AS TREATMENT OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY (DPN): A 13-WEEK RANDOMIZED CONTROLLED TRIAL AND 6-MONTH SAFETY EXTENSION

European Journal of Pain ◽

10.1016/j.ejpain.2007.03.305 ◽

2007 ◽

Vol 11 (S1) ◽

pp. S128-S129 ◽

Cited By ~ 1

Author(s):

J. Rosenstock ◽

J.C. Arezzo ◽

L. LaMoreaux ◽

T.K. Murphy ◽

L. Pauer ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Peripheral Neuropathy ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled ◽

(409) A Double-Blind, Placebo-Controlled, Phase 2 Study to Assess the Safety and Efficacy of NYX-2925 in Subjects with Painful Diabetic Peripheral Neuropathy

Journal of Pain ◽

10.1016/j.jpain.2019.02.094 ◽

2019 ◽

Vol 20 (4) ◽

pp. S73 ◽

Cited By ~ 1

Author(s):

S. Torri ◽

S. Sainati ◽

M. Burak ◽

J. Hamilton ◽

N. Katz ◽

...

Keyword(s):

Peripheral Neuropathy ◽

Phase 2 ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Painful Diabetic Peripheral Neuropathy ◽

Phase 2 Study

Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study

Journal of Pain ◽

10.1016/j.jpain.2016.09.008 ◽

2017 ◽

Vol 18 (1) ◽

pp. 42-53 ◽

Cited By ~ 48

Author(s):

David M. Simpson ◽

Jessica Robinson-Papp ◽

Joanna Van ◽

Malcolm Stoker ◽

Hélène Jacobs ◽

...

Keyword(s):

Peripheral Neuropathy ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

The Effect of γ-Linolenic Acid on Human Diabetic Peripheral Neuropathy: A Double-blind Placebo-controlled Trial

Diabetic Medicine ◽

10.1111/j.1464-5491.1990.tb01397.x ◽

1990 ◽

Vol 7 (4) ◽

pp. 319-323 ◽

Cited By ~ 80

Author(s):

G.A. Jamal ◽

H. Carmichael

Keyword(s):

Peripheral Neuropathy ◽

Linolenic Acid ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Efficacy and safety of pregabalin for painful diabetic peripheral neuropathy in a population of Chinese patients: A randomized placebo-controlled trial

Journal of Diabetes ◽

10.1111/1753-0407.12585 ◽

2017 ◽

Vol 10 (3) ◽

pp. 256-265 ◽

Cited By ~ 7

Author(s):

Yiming Mu ◽

Xiaomin Liu ◽

Quanmin Li ◽

Kangning Chen ◽

Yu Liu ◽

...

Keyword(s):

Peripheral Neuropathy ◽

Controlled Trial ◽

Chinese Patients ◽

Efficacy And Safety ◽

Efficacy and Safety of VM202 in Painful Diabetic Peripheral Neuropathy -The HOPES Trial

Case Medical Research ◽

10.31525/ct1-nct04087941 ◽

2019 ◽

Author(s):

Keyword(s):

Peripheral Neuropathy ◽

Efficacy And Safety ◽

Faculty Opinions recommendation of Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1088945.542078 ◽

2007 ◽

Author(s):

Jonathan Schapiro

Keyword(s):

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hiv 1